Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
LBBW Venture Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cloverleaf BioSeed $33M · this month • Founded 2023 • 51-200 employees • 3 roles
Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Unlocking evolutionary biology by translating nature’s molecules into medicines for patients with cancer and inflammatory diseases.
Cadenza Bio, Inc.Founded 2022 • 11-50 employees
Cadenza Bio is a preclinical biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of…
Octagon TherapeuticsVenture round $11M · 2 yr ago • Founded 2016 • 11-50 employees
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…
TrexBioVenture round $50M · 8 mo ago • Founded 2021 • 51-200 employees
Decoding Human T issue Biology to C reate Revolutionary T herapeutics. TRexBio is developing immunoregulatory medicines designed to restore…
KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.

Overview

Decoding RNA modifications to revolutionize cancer and inflammation treatment. Umlaut.bio GmbH is a pioneering biotech company focused on developing first-in-biology therapeutic molecules to modify tRNA and target cancers and inflammatory diseases.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1